Premium
Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial
Author(s) -
Choi C. H.,
Kwon J. G.,
Kim S. K.,
Myung S.J.,
Park K. S.,
Sohn C.I.,
Rhee P.L.,
Lee K. J.,
Lee O. Y.,
Jung H.K.,
Jee S. R.,
Jeen Y. T.,
Choi M.G.,
Choi S. C.,
Huh K. C.,
Park H.
Publication year - 2015
Publication title -
neurogastroenterology and motility
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.489
H-Index - 105
eISSN - 1365-2982
pISSN - 1350-1925
DOI - 10.1111/nmo.12544
Subject(s) - mosapride , placebo , medicine , diarrhea , double blind , irritable bowel syndrome , randomized controlled trial , gastroenterology , alternative medicine , pathology
Probiotics can be beneficial in irritable bowel syndrome (IBS). Mosapride citrate, a selective 5-HT4 receptor agonist, stimulates gastrointestinal motility. We investigated the efficacy of combination therapy with probiotics and mosapride for non-diarrheal-type IBS.